{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T16:45:53Z","timestamp":1767804353406,"version":"3.49.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,7]]},"DOI":"10.7759\/cureus.101005","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T15:04:50Z","timestamp":1767798290000},"source":"Crossref","is-referenced-by-count":0,"title":["Racial Disparities in Severe Cutaneous Adverse Reactions: A Report of Two Cases on Preventable Stevens-Johnson Syndrome\/Toxic Epidermal Necrolysis Prescription Errors Through Medication Stewardship"],"prefix":"10.7759","author":[{"given":"Kritin K","family":"Verma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merry A","family":"Mathew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tramondranique","family":"Hawkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brooke","family":"Waltersheid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dora R","family":"Goldstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sahil","family":"Kapur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kermanjot","family":"Sidhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ethan J","family":"Matthew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter S","family":"Herman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Tarbox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2013.05.002","article-title":"Toxic epidermal necrolysis: Part II. Prognosis, sequelae, diagnosis, differential diagnosis, prevention, and treatment","volume":"69","author":"Schwartz RA","year":"2013","unstructured":"Schwartz RA, McDonough PH, Lee BW. Toxic epidermal necrolysis: Part II. Prognosis, sequelae, diagnosis, differential diagnosis, prevention, and treatment. J Am Acad Dermatol. 2013, 69:187.e1-16. 10.1016\/j.jaad.2013.05.002","journal-title":"J Am Acad Dermatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2016.03.023","article-title":"Morbidity and mortality of Stevens-Johnson Syndrome and toxic epidermal necrolysis in United States adults","volume":"136","author":"Hsu DY","year":"2016","unstructured":"Hsu DY, Brieva J, Silverberg NB, Silverberg JI. Morbidity and mortality of Stevens-Johnson Syndrome and toxic epidermal necrolysis in United States adults. J Invest Dermatol. 2016, 136:1387-97. 10.1016\/j.jid.2016.03.023","journal-title":"J Invest Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2021.3154","article-title":"Assessment of treatment approaches and outcomes in Stevens-Johnson Syndrome and toxic epidermal necrolysis: Insights from a pan-European multicenter study","volume":"157","author":"Kridin K","year":"2021","unstructured":"Kridin K, Br\u00fcggen MC, Chua SL, et al.. Assessment of treatment approaches and outcomes in Stevens-Johnson Syndrome and toxic epidermal necrolysis: Insights from a pan-European multicenter study. JAMA Dermatol. 2021, 157:1182-90. 10.1001\/jamadermatol.2021.3154","journal-title":"JAMA Dermatol"},{"key":"ref4","article-title":"Stevens-Johnson Syndrome","author":"Oakley AM","year":"2025","unstructured":"Oakley AM, Krishnamurthy K. Stevens-Johnson Syndrome. StatPearls [Internet]. StatPearls Publishing, Treasure Island, FL; 2025."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.14740\/jocmr3906","article-title":"Overprescribed medications for US adults: Four major examples","volume":"11","author":"Safer DJ","year":"2019","unstructured":"Safer DJ. Overprescribed medications for US adults: Four major examples. J Clin Med Res. 2019, 11:617-22. 10.14740\/jocmr3906","journal-title":"J Clin Med Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.13766","article-title":"Trends in prescription drug use among adults in the United States from 1999-2012","volume":"314","author":"Kantor ED","year":"2015","unstructured":"Kantor ED, Rehm CD, Haas JS, Chan AT, Giovannucci EL. Trends in prescription drug use among adults in the United States from 1999-2012. JAMA. 2015, 314:1818-30. 10.1001\/jama.2015.13766","journal-title":"JAMA"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-024128","article-title":"Physicians' role in the development of inappropriate polypharmacy among older adults in Iran: A qualitative study","volume":"9","author":"Mortazavi SS","year":"2019","unstructured":"Mortazavi SS, Shati M, Malakouti SK, Khankeh HR, Mehravaran S, Ahmadi F. Physicians' role in the development of inappropriate polypharmacy among older adults in Iran: A qualitative study. BMJ Open. 2019, 9:e024128. 10.1136\/bmjopen-2018-024128","journal-title":"BMJ Open"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2016.03.014","article-title":"Racial disparities in the risk of Stevens-Johnson Syndrome and toxic epidermal necrolysis as urate-lowering drug adverse events in the United States","volume":"46","author":"Lu N","year":"2016","unstructured":"Lu N, Rai SK, Terkeltaub R, Kim SC, Menendez ME, Choi HK. Racial disparities in the risk of Stevens-Johnson Syndrome and toxic epidermal necrolysis as urate-lowering drug adverse events in the United States. Semin Arthritis Rheum. 2016, 46:253-8. 10.1016\/j.semarthrit.2016.03.014","journal-title":"Semin Arthritis Rheum"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.63922","article-title":"Drug reaction with eosinophilia and systemic symptoms syndrome preceding toxic epidermal necrolysis secondary to sildenafil: A case report","volume":"16","author":"Walterscheid B","year":"2024","unstructured":"Walterscheid B, Batchinsky M, Tarbox M. Drug reaction with eosinophilia and systemic symptoms syndrome preceding toxic epidermal necrolysis secondary to sildenafil: A case report. Cureus. 2024, 16:e63922. 10.7759\/cureus.63922","journal-title":"Cureus"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1080\/00015550510037062","article-title":"Toxic epidermal necrolysis associated with high intake of sildenafil and its response to infliximab","volume":"85","author":"Al-Shouli S","year":"2005","unstructured":"Al-Shouli S, Abouchala N, Bogusz MJ, Al Tufail M, Thestrup-Pedersen K. Toxic epidermal necrolysis associated with high intake of sildenafil and its response to infliximab. Acta Derm Venereol. 2005, 85:534-5. 10.1080\/00015550510037062","journal-title":"Acta Derm Venereol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/440586-racial-disparities-in-severe-cutaneous-adverse-reactions-a-report-of-two-cases-on-preventable-stevens-johnson-syndrometoxic-epidermal-necrolysis-prescription-errors-through-medication-stewardship","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T15:04:56Z","timestamp":1767798296000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/440586-racial-disparities-in-severe-cutaneous-adverse-reactions-a-report-of-two-cases-on-preventable-stevens-johnson-syndrometoxic-epidermal-necrolysis-prescription-errors-through-medication-stewardship"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,7]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.101005","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,7]]}}}